As per the current available research studies, COVID-19 is reported due to Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) and are affecting millions of people worldwide. The sudden outbreak of this highly contagion disease has the boosted the revenue of the pharmaceutical industry and impelling the industry to work more than their original production capacity. The key companies are highly engaged in the research and development activities for both to develop therapeutic medicine and for preventive interventions. The global COVID-19 treatment market is expected to grow at a significant CAGR during the forecast period 2020-2026.
GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC71
Rapid growth in number of coronavirus infected cases in the world is increasingly demanding the short- and long-term respiratory support for patients through various methods. The contagious disease is impacting the economies at hardest due to lockdown in major economies. The pharmaceutical sector is no behind the impact due to non-effective working condition of manufacturing sites and supply chains across the world.
Segmentation Overview of the Global COVID-19 Treatment Market
The global Covid-19 Treatment Market is analysed for different market segments and their sub-segments for an insightful market analysis and results. Such market segmentation has been done on the basis of type and application. These major market segments are further categorised into various sub-segments, such as:
Based on type, the global Covid-19 Treatment Market is Sub-Segmented into:
- Treatment TypeCirculatory Support
- Respiratory Support
- Oxygen Therapy
- Non-Invasive Mechanical Ventilation or High-Flow Nasal Catheter Oxygen Therapy
- Invasive Mechanical Ventilation
- Extracorporeal Membrane Pneumonectomy (ECMO)
- Respiratory Support
- Convalescent Plasma Therapy
- Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)
- Antimicrobial Therapy
- Renal Failure and Renal Replacement Therapy
- Lung Replacement Therapy
- Other therapeutic measures
- Severity Degree
Based on Application, the global Covid-19 Treatment Market is Sub-Segmented into:
- Special Groups such as Pregnant Women
Geographical Overview of the Global COVID-19 Treatment Market
According to the World Health Organization, SARS-CoV-2 has spread to over 209 countries and territories with over 1,431,750 confirmed cases and over 82,080 deaths as of 8th April 2020. On the basis of geographical segmentation, the global COVID-19 treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa (MEA). As per the analysis, the North American market is dominating the global market, owing to high number of COVID-19 cases in the United States which require rapid number of testing in the near future to contain the spread of disease in the region. On the other hand, the Asia-Pacific is expected to grow at fastest CAGR during the forecast period, owing to large scale of population base in the countries such as India and China.
Key Players Insights
Clover Biopharmaceuticals, ExpreS2ion Biotechnologies ApS, CanSino Biologics, Inc., Greffex Inc., Altimmune, Janssen Pharmaceuticals, Ascletis Pharma, Bravovax, Novavax, Moderna Therapeutics, Generex Biotechnology Corporation, MIGAL Galilee Research Institute, Zydus Cadila, Evvivax, Takis Biotech, GeoVax Labs, Inc., and Codagenix and Sciences, Inc. among others are some market players included in the research study of the global COVID-19 Treatment market. The market players are majorly focusing on product launches and boosting their research and development activities to gain majority of the market share for the long-term.
Get More Information About This Report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC71
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Address:Classic Tower, Rajnagar Extension
State: UP, 201017